Anonymous
Guest
Anonymous
Guest
All over the headlines for selling a 6 week drug for 84,000. You should be ashamed of yourselves! Pathetic!!!!
That aint going to help with the Jury
Amen! The 1%ers get richer and the 99% are kicked in the balls!
All over the headlines for selling a 6 week drug for 84,000. You should be ashamed of yourselves! Pathetic!!!!
This reflects overall healthcare cost, not a greedy company. Research, FDA....what it takes to get drug to market. On top of all this, it is within market value but costs a premium as all best in class products do.
Stop crying cost and celebrate a cure!
Gilead didn't even invent their drug - - - slimy pigs!
Roche (OTCQX:RHHBY) has argued that it had partnership with Pharmasset since 2004 and that gives it an exclusive license to the drug. Gilead rejected the argument by pointing out that the partnership has ended long before Gilead's acquisition of Pharmasset.
Abbvie (ABBV) has filed suit against Gilead in February in a Delaware court for infringement of its patent Nos. 8,466,159 ("Methods for Treating HCV," issued in June, 2013) and 8,492,386 (same title, issued in July, 2013) based on Gilead's anticipated manufacture and sale of its combination therapy of Sovaldi and ledipasvir.
Merck (MRK) last summer contacted Gilead by phone calls and email and asked for a 10 percent royalty, maintaining that the drug infringes on its patent Nos. 71,905,499 and 8,481,712, a claim that Gilead considers a threat to the company.
This reflects overall healthcare cost, not a greedy company. Research, FDA....what it takes to get drug to market. On top of all this, it is within market value but costs a premium as all best in class products do.
Stop crying cost and celebrate a cure!
Seriously?? Are you in the CA home office?? Is "what it takes to get a drug to market" why you pay off your speakers $3000 plus to do a 45 min talk? Reprehensible!
Gilead has caused the whole biotech sector to tank in the markets
Express Scripts won't fill my Rx?! What's Up?